 |
|
Post–Coronavirus Disease 2019 Pulmonary Fibrosis: Wait or Needs Intervention
Hee-Young Yoon, Soo-Taek Uh
Tuberc Respir Dis. 2022;85(4):320-331. Published online 2022 Jun 20 DOI: https://doi.org/10.4046/trd.2022.0053
|
|
Citations to this article as recorded by
 Increased Risk of New-Onset Asthma After COVID-19: A Nationwide Population-Based Cohort Study
Bo-Guen Kim, Hyun Lee, Sang Woo Yeom, Cho Yun Jeong, Dong Won Park, Tai Sun Park, Ji-Yong Moon, Tae-Hyung Kim, Jang Won Sohn, Ho Joo Yoon, Jong Seung Kim, Sang-Heon Kim
The Journal of Allergy and Clinical Immunology: In Practice.2024; 12(1): 120. CrossRef Risk of newly diagnosed interstitial lung disease after COVID-19 and impact of vaccination: a nationwide population-based cohort study
Bo-Guen Kim, Hyun Lee, Cho Yun Jeong, Sang Woo Yeom, Dong Won Park, Tai Sun Park, Ji-Yong Moon, Tae-Hyung Kim, Jang Won Sohn, Ho Joo Yoon, Jong Seung Kim, Sang-Heon Kim
Frontiers in Public Health.2024;[Epub] CrossRef Integrative single‐cell transcriptome analysis provides new insights into post‐COVID‐19 pulmonary fibrosis and potential therapeutic targets
Yumin Kim, Yeongmin Kim, Hyobin Julianne Lim, Dae‐Kyum Kim, Ji‐Hwan Park, Chang‐Myung Oh
Journal of Medical Virology.2023;[Epub] CrossRef
|